These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31335444)

  • 21. Observations from 8 cases of clozapine rechallenge after development of myocarditis.
    Ronaldson KJ; Fitzgerald PB; Taylor AJ; McNeil JJ
    J Clin Psychiatry; 2012 Feb; 73(2):252-4. PubMed ID: 22401481
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful management of clozapine adverse effects with extended (alternate day) antipsychotic dosing in a patient with schizophrenia.
    Kumar V; Sharma L; Madival S; Venkatasubramanian G
    J Psychiatry Neurosci; 2016 Jan; 41(1):E1-2. PubMed ID: 26674512
    [No Abstract]   [Full Text] [Related]  

  • 23. Clozapine-associated severe eosinophilia following lithium rebound neutropenia: A case report.
    Kikuchi K; Yasui-Furukori N; Yokoyama S; Hasegawa C; Kokubun A; Katsukura S; Shimizu T; Shimoda K
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):388-391. PubMed ID: 32951324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Eosinophilic colitis caused by clozapine].
    de Raad AW; Siegersma NC; Clahsen PC; Hagestein-de Bruijn C
    Ned Tijdschr Geneeskd; 2011; 155(36):A3620. PubMed ID: 21914234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful clozapine rechallenge following prior intolerance to clozapine.
    Cohen SA
    J Clin Psychiatry; 1994 Nov; 55(11):498-9. PubMed ID: 7989287
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N; Myles H; Clark SR; Bird R; Siskind D
    Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine-Associated Myocarditis: A Protocol for Monitoring Upon Clozapine Initiation and Recommendations for How to Conduct a Clozapine Rechallenge.
    Griffin JM; Woznica E; Gilotra NA; Nucifora FC
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):180-185. PubMed ID: 33587399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clozapine-induced toxic hepatitis with skin rash.
    Fong SY; Au Yeung KL; Tosh JM; Wing YK
    J Psychopharmacol; 2005 Jan; 19(1):107. PubMed ID: 15671137
    [No Abstract]   [Full Text] [Related]  

  • 29. Clozapine-induced eosinophilia and serositis.
    Demelo-Rodríguez P; de Miguel-Yanes JM; Gómez-Vallejo S
    Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(2):130-131. PubMed ID: 30808609
    [No Abstract]   [Full Text] [Related]  

  • 30. Clozapine-induced esophagitis at therapeutic dose: a case report.
    Gonçalves B; Castro J; Zanini MA; Bittencourt L; Gadelha A; Cunha GR; Coelho FM; Tufik S; Bressan RA; Brietzke E
    Braz J Psychiatry; 2016; 38(2):176-177. PubMed ID: 27304761
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety of clozapine in a woman with triplet pregnancy: A case report.
    Sreeraj VS; Venkatasubramanian G
    Asian J Psychiatr; 2016 Aug; 22():67-8. PubMed ID: 27520896
    [No Abstract]   [Full Text] [Related]  

  • 32. Optimizing outcomes in clozapine rechallenge following neutropenia using human leukocyte antigen typing: A case report.
    Yamaki N; Hishimoto A; Otsuka I; Sasada T; Boku S; Saito T; Yasuda Y; Yamamori H; Ikeda M; Ikeda M; Sora I; Iwata N; Hashimoto R
    Psychiatry Clin Neurosci; 2017 Apr; 71(4):289-290. PubMed ID: 28097743
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clozapine treatment of schizophrenia caused eosinophilia].
    Osby U; Durling A
    Lakartidningen; 1992 Jun; 89(26-27):2372-3. PubMed ID: 1507947
    [No Abstract]   [Full Text] [Related]  

  • 34. Clozapine-induced eosinophilia: subsequent neutropenia and corresponding allergic mechanisms.
    Lucht MJ; Rietschel M
    J Clin Psychiatry; 1998 Apr; 59(4):195-7. PubMed ID: 9590673
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful re-exposure to clozapine after eosinophilia and clinically suspected myocarditis.
    Granja-Ingram NM; James J; Clark N; Stovall J; Heckers S
    Braz J Psychiatry; 2013 Mar; 35(1):95-6. PubMed ID: 23567609
    [No Abstract]   [Full Text] [Related]  

  • 36. Recurrent pancreatitis without eosinophilia on clozapine rechallenge.
    Huang YJ; Lane HY; Liao CH; Huang CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1561-2. PubMed ID: 19735691
    [No Abstract]   [Full Text] [Related]  

  • 37. Eosinophilia, agranulocytosis and clozapine.
    Adityanjee MD; Jampala VC; Mohen MS
    Br J Psychiatry; 1997 Nov; 171():485-6. PubMed ID: 9463617
    [No Abstract]   [Full Text] [Related]  

  • 38. Controls on clozapine must be reviewed.
    Drew LR
    Aust N Z J Psychiatry; 2010 May; 44(5):490. PubMed ID: 20397797
    [No Abstract]   [Full Text] [Related]  

  • 39. Clozapine-associated asterixis: case report.
    Kwak YT; Yang Y; Koo MS
    J Clin Psychopharmacol; 2014 Feb; 34(1):165-7. PubMed ID: 24158019
    [No Abstract]   [Full Text] [Related]  

  • 40. Managing clozapine discontinuation - acute and chronic maintenance strategies.
    Shields MK; Bastiampillai T; Mohan T
    Aust N Z J Psychiatry; 2012 Nov; 46(11):1104-5. PubMed ID: 23104931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.